Work

CD95/Fas-ligation and resting NK or IL-2 activated NK (LAK) attack limit NK-92 efficacy.

Year: 2022

Type: conference-abstract

Source: The Journal of Immunology

DOI: 10.4049/jimmunol.208.supp.62.03

Authors: Lydia T Navarrete-Galvan, Michael Guglielmo, Judith Cruz Amaya, Rebecca Merica, Julie Smith-Gagen, Vincent C Lombardi, Dorothy Hudig

Institutions: University of Nevada, Reno, Fred Hutch Cancer Center, St. Olaf College

Language: English

Topic: Immune Cell Function and Interaction

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4313404905

Cites:

Cited by:

Related to: 10